Using behavior to elucidate receptor mechanisms: A review of the discriminative stimulus effects of benzodiazepines

被引:28
作者
Lelas, S [1 ]
Spealman, RD [1 ]
Rowlett, JK [1 ]
机构
[1] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Behav Biol, Southborough, MA 01772 USA
关键词
D O I
10.1037/1064-1297.8.3.294
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Drug discrimination procedures have been used to study receptor mechanisms of benzodiazepine (BZ) agonists with the goal of developing new therapeutic agents that retain positive effects of conventional BZ ligands yet have reduced side effects. The present review provides a synthesis of existing literature on discriminative stimulus effects of BZ agonists in order to elucidate their underlying receptor mechanisms, specifically in terms of intrinsic efficacy and receptor selectivity. The available evidence suggests that receptor selectivity is a critical determinant of the discriminative stimulus effects of BZ agonists. In particular, BZ-1 receptors appear to play a fundamental role, whereas the role of BZ-2 receptors remains elusive. In addition, data from many drug discrimination studies suggest that the conventional BZ agonist chlordiazepoxide may have reduced intrinsic efficacy compared with other BZ agonists.
引用
收藏
页码:294 / 311
页数:18
相关论文
共 179 条
[1]  
Acri JB, 1996, BEHAV PHARMACOL, V7, P72
[2]   STEREOSPECIFIC TRANSDUCTION OF BEHAVIORAL-EFFECTS VIA DIAZEPAM-INSENSITIVE GABA(A) RECEPTORS [J].
ACRI, JB ;
WONG, G ;
WITKIN, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (03) :213-223
[3]  
ANDREWS JS, 1991, BEHAV PHARMACOL, V2, P171
[4]   GUIDELINES FOR THE RATIONAL USE OF BENZODIAZEPINES - WHEN AND WHAT TO USE [J].
ASHTON, H .
DRUGS, 1994, 48 (01) :25-40
[5]  
Ator N. A., 1992, Society for Neuroscience Abstracts, V18, P1158
[6]   DRUG DISCRIMINATION IN PENTYLENETETRAZOL-TRAINED BABOONS - GENERALIZATION TO BUSPIRONE AND BETA-CARBOLINE-3-CARBOXYLIC ACID ETHYL-ESTER BUT NOT LORAZEPAM OR PENTOBARBITAL [J].
ATOR, NA ;
COOK, JM ;
GRIFFITHS, RR .
DRUG DEVELOPMENT RESEARCH, 1989, 16 (2-4) :257-267
[7]   LORAZEPAM AND PENTOBARBITAL DISCRIMINATION - INTERACTIONS WITH CGS-8216 AND CAFFEINE [J].
ATOR, NA ;
GRIFFITHS, RR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 107 (02) :169-181
[8]   DRUG DISCRIMINATION AND DRUG STIMULUS-GENERALIZATION WITH ANXIOLYTICS [J].
ATOR, NA .
DRUG DEVELOPMENT RESEARCH, 1990, 20 (02) :189-204
[9]  
ATOR NA, 1986, J PHARMACOL EXP THER, V237, P393
[10]  
Ator NA, 1999, J PHARMACOL EXP THER, V289, P1434